Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification

Cited by (262)

Items 101–200 of 262

1. Selection on synonymous sites: the unwanted transcript hypothesis
   Sofia Radrizzani, Grzegorz Kudla, Zsuzsanna Izsvák, Laurence D. Hurst · 2024 · Nature Reviews Genetics
2. Pre-clinical non-viral vectors exploited for in vivo CRISPR/Cas9 gene editing: an overview
   Nadia Rouatbi, Tasneem McGlynn, Khuloud T. Al‐Jamal · 2022 · Biomaterials Science
3. mRNA-Based Vaccines and Mode of Action
   Janina Gergen, Benjamin Petsch · 2020 · Current topics in microbiology and immunology
4. mRNA-based modalities for infectious disease management
   Mengjie Zhang, Abid Hussain, Haiyin Yang, Jinchao Zhang, Xing‐Jie Liang, Yuanyu Huang · 2022 · Nano Research
5. Targeted degradation of PCNA outperforms stoichiometric inhibition to result in programed cell death
   Chang, Shih Chieh, Gopal, Pooja, Lim, Shuhui, Wei, Xiaona, Chandramohan, Arun, Mangadu, Ruban, Smith, Jeffrey, Ng, Simon, Gindy, Marian, Phan, Uyen et al. · 2022 · Cell Chemical Biology
6. mRNA-based therapeutic strategies for cancer treatment
   Thilelli Taibi, Sehyun Cheon, Fabiana Perna, Ly Vu · 2024 · Molecular Therapy
7. Nanomaterial-assisted CRISPR gene-engineering – A hallmark for triple-negative breast cancer therapeutics advancement
   Jabeen Farheen, Narayan S. Hosmane, Ruibo Zhao, Qingwei David Zhao, M. Zubair Iqbal, Xiangdong Kong · 2022 · Materials Today Bio
8. Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy
   Bevin Neill, Adriana Retamales Romero, Owen S. Fenton · 2023 · ACS Applied Bio Materials
9. Recent Progress in Nucleic Acid Pulmonary Delivery toward Overcoming Physiological Barriers and Improving Transfection Efficiency
   Qiyue Wang, Chaozhi Bu, Qihao Dai, Jinhua Chen, Ruitao Zhang, Xiaomin Zheng, Hao Ren, Xiaofei Xin, Xueming Li · 2024 · Advanced Science
10. mRNAid, an open-source platform for therapeutic mRNA design and optimization strategies
    Nikita Vostrosablin, Shuhui Lim, Pooja Gopal, Kveta Brazdilova, Sushmita Parajuli, Xiaona Wei, Anna Gromek, David Příhoda, Martin Spale, Anja Muždalo et al. · 2024 · NAR Genomics and Bioinformatics
11. A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach
    Shunping Feng, Nino Rcheulishvili, Xiaoming Jiang, Pan Zhu, Xuehua Pan, Meilan Wei, Peng George Wang, Yang Ji, Dimitri Papukashvili · 2024 · International Journal of Biological Sciences
12. mRNA therapeutics: Transforming medicine through innovation in design, delivery, and disease treatment
    Mark Akinola Ige, Xiaohu Ren, Yang Yang, Haiping Zhang, Chenguang Shen, Yushan Jiang, Junxin Li, Xiaochun Wan · 2025 · Molecular Therapy — Nucleic Acids
13. Design and development of mRNA and self-amplifying mRNA vaccine nanoformulations
    Yadollah Omidi, Mohammad Mostafa Pourseif, Rais Ahmad Ansari, Jaleh Barar · 2024 · Nanomedicine
14. Advancing mRNA technologies for therapies and vaccines: An African context
    Kairuz, Dylan, Samudh, Nazia, Ely, Abdullah, Arbuthnot, Patrick, Bloom, Kristie · 2022 · Frontiers in Immunology
15. Quantitative profiling of human translation initiation reveals elements that potently regulate endogenous and therapeutically modified mRNAs
    Lewis, Cole J.T., Xie, Li H., Bhandarkar, Shivani Milind, Jin, Danni, Abdallah, Kyrillos, Draycott, Austin S., Chen, Yixuan, Thoreen, Carson C., Gilbert, Wendy V. · 2025 · Molecular Cell
16. Alleviation of ischemia-reperfusion induced renal injury by chemically modified SOD2 mRNA delivered via lipid nanoparticles
    Yutong Hou, Sihao Lin, Jia Xia, Yu Zhang, Yanan Yin, Masha Huang, Yingjie Xu, Wen Yi Yang, Yingjian Zhu · 2023 · Molecular Therapy — Nucleic Acids
17. A single-nucleotide resolution capillary gel electrophoresis workflow for poly(A) tail characterization in the development of mRNA therapeutics and vaccines
    Deanna Di Grandi, Daniel M. Dayeh, Keerat Kaur, Yizhuo Chen, Steven Henderson, Youmi Moon, Arijit Bhowmick, Peter M. Ihnat, Yue Fu, Kathir Muthusamy et al. · 2023 · Journal of Pharmaceutical and Biomedical Analysis
18. RETRACTED ARTICLE: Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact
    Saber İmani, Oya Tagit, Chantal Pichon · 2024 · npj Vaccines · Retracted
19. Advances in modification and delivery of nucleic acid drugs
    Junfeng Wang, Manman Tan, Ying Wang, Xiangrui Liu, Aifu Lin · 2023 · Journal of Zhejiang University (Medical Sciences)
20. Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach
    Falak Goyal, Anandini Chattopadhyay, Umashanker Navik, Aklank Jain, P. Hemachandra Reddy, Gurjit Kaur Bhatti, Jasvinder Singh Bhatti · 2023 · Advanced Therapeutics
21. Exploring the Potential and Challenges of CRISPR Delivery and Therapeutics for Genetic Disease Treatment
    Xinpu Yang, Thuy Anh Bui, Haoqi Mei, Yagiz Alp Aksoy, Fei Deng, György Hutvágner, Wei Deng · 2024 · Advanced Functional Materials
22. Strategies for improving the genome-editing efficiency of class 2 CRISPR/Cas system
    Linli Wang, Hongbing Han · 2024 · Heliyon
23. CRISPR-derived genome editing therapies: Progress from bench to bedside
    Holly A. Rees, Alex C. Minella, Cameron A. Burnett, Alexis C. Komor, Nicole M. Gaudelli · 2021 · Molecular Therapy
24. Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases
    Dana H. Elkhalifa, Menatallah Rayan, Ahmed T. Negmeldin, Abdelbary M. A. Elhissi, Ashraf A. Khalil · 2021 · Biomedicine & Pharmacotherapy
25. mRNA delivery technologies: Toward clinical translation
    Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Marina Beraza-Millor, Alicia Rodríguez‐Gascón, Ana del Pozo‐Rodríguez, Maria Ángelés Solinís · 2022 · International review of cytology
26. The mRNA vaccine, a swift warhead against a moving infectious disease target
    Sheema Mir, Mohammad Ayoub Mir · 2024 · Expert Review of Vaccines
27. mRNA Therapies: New Hope in the Fight against Melanoma
    Melissa van Dülmen, Andrea Rentmeister · 2020 · Biochemistry
28. Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development
    Paula M. Cannon, Aravind Asokan, Agnieszka D. Czechowicz, Paula Therese Hammond, Donald B. Kohn, André Lieber, Punam Malik, Peter W Marks, Matthew Hebden Porteus, Els Verhoeyen et al. · 2021 · Human Gene Therapy
29. mRNA medicine: Recent progresses in chemical modification, design, and engineering
    Xiaowen Hou, Jinjun Shi, Yuling Xiao · 2024 · Nano Research
30. Exploring the Impact of In Vitro-Transcribed mRNA Impurities on Cellular Responses
    Julien Camperi, Brian Roper, Emily C. Freund, Rebecca A. Leylek, Ariane Nissenbaum, Carolina Galan, Roger H. Caothien, Zhilan Hu, Peggy Ko, Allison Lee et al. · 2024 · Analytical Chemistry
31. The Progress and Evolving Trends in Nucleic-Acid-Based Therapies
    Yunlong Liu, Chunmiao Wang, Xiuping Fu, Mengtian Ren · 2025 · Biomolecules
32. Cancer mRNA vaccines: clinical application progress and challenges
    Hang Li, Lang Min, Haotian Du, Xiawei Wei, Aiping Tong · 2025 · Cancer Letters
33. The clinical progress and challenges of mRNA vaccines
    Meng‐Zhen Yu, Nannan Wang, Jia‐Qing Zhu, Yao‐Xin Lin · 2023 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
34. SMART-lipid nanoparticles enabled mRNA vaccine elicits cross-reactive humoral responses against the omicron sub-variants
    Gokulnath Mahalingam, Hari Krishnareddy Rachamalla, Porkizhi Arjunan, Karthik V. Karuppusamy, Yogapriya Periyasami, Aruna Mohan, Kanimozhi Subramaniyam, Salma M, Vigneshwar Rajendran, Mahesh Moorthy et al. · 2024 · Molecular Therapy
35. RNA nanomedicine in liver diseases
    Anita K. Bakrania, Yulin Mo, Gang Zheng, Mamatha Bhat · 2023 · Hepatology
36. A review of RNA nanoparticles for drug/gene/protein delivery in advanced therapies: Current state and future prospects
    Pegah Vosoughi, Seyed Morteza Naghib, Babak Mikaeeli Kangarshahi, Mohammad Reza Mozafari · 2025 · International Journal of Biological Macromolecules
37. CRISPR–Cas technologies in neurodegenerative disorders: mechanistic insights, therapeutic potential, and translational challenges
    Raya Kh. Yashooa, Ari Qadir Nabi, Shukur Wasman Smail, Sarkar Sardar Azeez, Wissam Albeer Nooh, Suhad Asad Mustafa, Abd Al-Bar Al-Farha, Nazzareno Capitanio, Mudhir Sabir Shekha · 2026 · Frontiers in Neurology
38. mRNA produced by VSW-3 RNAP has high-level translation efficiency with low inflammatory stimulation
    Guoquan Wang, Rui Cheng, Qiubing Chen, Yuandong Xu, Bingbing Yu, Bin Zhu, Hao Yin, Heng Xia · 2022 · Cell Insight
39. Robust genome editing via modRNA-based Cas9 or base editor in human pluripotent stem cells
    Tahir Haideri, Alessandro R. Howells, Yuqian Jiang, Jian Yang, Xiaoping Bao, Xiaojun Lance Lian · 2022 · Cell Reports Methods
40. C-Ribosylating Enzymes in the (Bio)Synthesis of C-Nucleosides and C-Glycosylated Natural Products
    Martin Pfeiffer, Bernd Nidetzky · 2023 · ACS Catalysis
41. Protocol for Delivery of CRISPR/dCas9 Systems for Epigenetic Editing into Solid Tumors Using Lipid Nanoparticles Encapsulating RNA
    Eleanor Woodward, Edina Wang, Christopher J. D. Wallis, Rohit Kumar Sharma, Ash W J Tie, Niren Murthy, Pilar Blancafort · 2024 · Methods in molecular biology
42. Potential therapeutic strategy for cancer: Multi-dimensional cross-talk between circRNAs and parental genes
    Xiaoyu Sun, Xinyi Zhao, Yan Xu, Yuanyuan Yan, Han Li, Minjie Wei, Miao He · 2024 · Cancer Letters
43. DNA-terminus-dependent transcription by T7 RNA polymerase and its C-helix mutants
    Bingbing Yu, Yifan Chen, Yan Yan, Xueling Lu, Bin Zhu · 2024 · Nucleic Acids Research
44. mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People
    Anna Rosa Garbuglia, Claudia Minosse, Paola Del Porto · 2022 · Viruses
45. Nucleoside modifications of in vitro transcribed mRNA to reduce immunogenicity and improve translation of prophylactic and therapeutic antigens
    Mohamad‐Gabriel Alameh, Drew Weissman · 2022 · Elsevier eBooks
46. Delivery of mRNA for cancer therapy: progress and prospects
    Lin-Jia Su, Mo-Xi Xu, Zi-Han Ji, Jia-Qing Zhu, Meng‐Zhen Yu, Yi Wang, Yao‐Xin Lin · 2023 · Nano Today
47. mRNA vaccine development and applications: A special focus on tumors (Review)
    Bangjie Chen, Yipin Yang, Xinyi Wang, Wenzhi Yang, You Lu, Daoyue Wang, Enba Zhuo, Yanchao Tang, Junhong Su, Guozheng Tang et al. · 2024 · International Journal of Oncology
48. mRNA Treatment Rescues Niemann–Pick Disease Type C1 in Patient Fibroblasts
    Denzil L. Furtado, Christina Cortez‐Jugo, Ya Hui Hung, Ashley Ian Bush, Frank Caruso · 2022 · Molecular Pharmaceutics
49. CRISPR medicine for blood disorders: Progress and challenges in delivery
    Tahereh Mohammadian Gol, Guillermo Ureña-Bailén, Yujuan Hou, Ralph Sinn, Justin S. Antony, Rupert Handgretinger, Markus Mezger · 2023 · Frontiers in Genome Editing
50. Increasing Gene Editing Efficiency via CRISPR/Cas9- or Cas12a-Mediated Knock-In in Primary Human T Cells
    Natalia A. Kruglova, Mikhail V. Shepelev · 2024 · Biomedicines
51. Treatment of Anderson-Fabry Disease
    Irene Simonetta, Antonino Tuttolomondo, Mario Daidone, Salvatore Miceli, Antonio Ventura Pinto · 2020 · Current Pharmaceutical Design
52. Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
    Made Harumi Padmaswari, Shilpi Agrawal, Mary S. Jia, Allie Ivy, Daniel A. Maxenberger, Landon A. Burcham, Christopher E. Nelson · 2023 · Biophysics Reviews
53. Viral and nonviral nanocarriers for in vivo CRISPR-based gene editing
    Zhongyuan Guo, Audrey T. Zhu, Ronnie H. Fang, Liangfang Zhang · 2024 · Nano Research
54. Immunology of RNA-based vaccines: The critical interplay between inflammation and expression
    John S. Tregoning, Ziyin Wang, Saranya Sridhar, Robin J. Shattock, Frank DeRosa · 2025 · Molecular Therapy
55. Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
    Wubetu Yihunie Belay, Getinet Nibret, Yibeltal Aschale · 2023 · Clinical Pharmacology Advances and Applications
56. Nanoparticles‐Mediated CRISPR/Cas Gene Editing Delivery System
    Phei Er Saw, Guo‐hui Cui, Xiaoding Xu · 2022 · ChemMedChem
57. Current approaches and potential challenges in the delivery of gene editing cargos into hematopoietic stem and progenitor cells
    Ramya Murugesan, Karthik V. Karuppusamy, Srujan Kumar Marepally, Saravanabhavan Thangavel · 2023 · Frontiers in Genome Editing
58. Multiplex base editing to protect from CD33 directed drugs for immune and gene therapy
    Florence Borot, Olivier Humbert, Jeffrey T. Ehmsen, Emily Fields, Sajeev Kohli, Stefan Radtke, Kyle Swing, Dnyanada Pande, Mark Enstrom, George S. Laszlo et al. · 2025 · Nature Communications
59. Large-scale manufacturing of base-edited chimeric antigen receptor T cells
    Rosie Woodruff, Farhaan Parekh, Katarina Lamb, Leila Mekkaoui, Christopher G. Allen, Katerina Smetanova, Jasmine L. Huang, Alex Williams, Gerardo Santiago Toledo, Koki Lilova et al. · 2023 · Molecular Therapy — Methods & Clinical Development
60. JAX-RNAfold: scalable differentiable folding
    Ryan Krueger, Max Ward · 2025 · Bioinformatics
61. Polyplex Nanomicelle‐Mediated Pgc‐1α4 mRNA Delivery Via Hydrodynamic Limb Vein Injection Enhances Damage Resistance in Duchenne Muscular Dystrophy Mice
    Xuan Du, Hideyuki Nakanishi, Takashi Yamada, Yooksil Sin, Katsura Minegishi, Norio Motohashi, Yoshitsugu Aoki, Keiji Itaka · 2025 · Advanced Science
62. Unlocking mRNA-driven CRISPR-Cas9 gene therapy via optimizing mRNA and the delivery vectors
    Shengyi Wang, Xiaoyu Xu, Tapani Viitala, Yilai Shu, Hongbo Zhang · 2025 · Molecular Therapy — Nucleic Acids
63. Single-stranded DNA with internal base modifications mediates highly efficient knock-in in primary cells using CRISPR-Cas9
    Karen L Kanke, Rachael E. Rayner, Jack Bozik, Eli Abel, Aparna Venugopalan, Ma Suu, Reza Nouri, Jacob T. Stack, Gongbo Guo, Tatyana A. Vetter et al. · 2024 · Nucleic Acids Research
64. RNA Vaccines: Yeast as a Novel Antigen Vehicle
    Anna Jéssica Duarte Silva, Mylenna Máyra Gois de Sousa, Larissa Silva de Macêdo, Pedro Luis Franca-Neto, Ingrid Andrêssa de Moura, Benigno Cristofer Flores Espinoza, Maria da Conceição Viana Invenção, Samara Sousa de Pinho, Marco Antonio Turiah Machado da Gama, Antônio Carlos de Freitas · 2023 · Vaccines
65. Coding Therapeutic Nucleic Acids from Recombinant Proteins to Next-Generation Vaccines: Current Uses, Limitations, and Future Horizons
    Gamaleldin I. Harisa, Tarek M. Faris, Abdelrahman Y. Sherif, Riyad F. Alzhrani, Saleh A. Alanazi, Neveen A. Kohaf, Fars Kaed Alanazi · 2023 · Molecular Biotechnology
66. CRISPR/Cas-Based Gene Editing Strategies for DOCK8 Immunodeficiency Syndrome
    Sujan Ravendran, Sabina Sánchez Hernández, Saskia König, Rasmus Otkjær Bak · 2022 · Frontiers in Genome Editing
67. Engineered mRNAs With Stable Structures Minimize Double-stranded RNA Formation and Increase Protein Expression
    Qianshan Qin, Huayuan Yan, Weixiang Gao, Ruyin Cao, Guopeng Liu, Xiaojing Zhang, Niangang Wang, Wenjie Zuo, Lei Yuan, Peng Gao et al. · 2024 · Journal of Molecular Biology
68. Enhanced Epigenetic Modulation via mRNA-Encapsulated Lipid Nanoparticles Enables Targeted Anti-inflammatory Control
    Tahere Mokhtari, Mohammad Nasser Taheri, Sarah Akhlaghi, Armin Aryannejad, Yuda Xiang, Vineet Mahajan, Kamyar Keshavarz F., Amirreza Kiani, Samantha Yang, Samuel T. LoPresti et al. · 2026 · ACS Synthetic Biology
69. Protein-Based Systems for Translational Regulation of Synthetic mRNAs in Mammalian Cells
    Hideyuki Nakanishi · 2021 · Life
70. mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing—Insights From COVID‐19 as a Model for Combating Infectious Diseases
    Saeideh Khorshid Sokhangouy, Matine Behzadi, Shokuh Rezaei, Mahsa Farjami, Milad Haghshenas, Yahya Sefidbakht, Sina Mozaffari‐Jovin · 2025 · Biotechnology Journal
71. mRNA-Based Therapeutics: Advances in Drug Delivery, Comparative Innovations, and Biomedical Applications
    Radhika Joshi, Swapnil Sharma, Devesh U. Kapoor, Bhupendra G. Prajapati, Kampanart Huanbutta, Pornsak Sriamornsak · 2026 · Molecular Pharmaceutics
72. RNA sensor response in HeLa cells for transfected mRNAs prepared in vitro by SP6 and HiT7 RNA polymerases: A comparative study
    Siranjeevi Nagaraj, Anna Stankiewicz-Drogoń, Edward Darżynkiewicz, Renata Grzela · 2022 · Frontiers in Bioengineering and Biotechnology
73. Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders
    Valentina Buffa, José Roberto Alvarez Vargas, Anne H. M. Galy, Simone Spinozzi, Céline J. Rocca · 2023 · Frontiers in Genome Editing
74. Delivery of gene editing therapeutics
    Bhavesh D. Kevadiya, Farhana S. Islam, Pallavi Deol, Lubaba A. Zaman, Dina A. Mosselhy, Md Ashaduzzaman, Neha Bajwa, Nanda Kishore Routhu, Preet Amol Singh, Shilpa Dawre et al. · 2023 · Nanomedicine Nanotechnology Biology and Medicine
75. Predicting the Efficacy and Safety of TACTICs (Tumor Angiogenesis-Specific CAR-T Cells Impacting Cancers) Therapy for Soft Tissue Sarcoma Patients
    Kento Fujiwara, Shigemi Sasawatari, Sho Nakai, Keisuke Imaeda, Seina Nagai, Yoshihiro Matsuno, Kanako C. Hatanaka, Yutaka Hatanaka, Satoshi Takenaka, Naoki Okada · 2020 · Cancers
76. Emergence of Small Nucleic Acids as Drugs in Precision Medicine
    Xing Cheng, Yan Wang, Tingting Zhang, Yuening Cao, Hongbin Cheng, Yong Du, Xian Ge, Bo Ren, Jun Guo Lu, Liuying Li · 2025 · Clinical Pharmacology & Therapeutics
77. Therapeutic Application of mRNA for Genetic Diseases
    Paul J. L. Schürmann, Stijn v. Breda Vriesman, Jose Castro-Alpízar, Sander A. A. Kooijmans, Edward E. S. Nieuwenhuis, Raymond Michel Schiffelers, Sabine A. Fuchs · 2025 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
78. Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2
    Jiin H. Felgner, Jenny E. Hernandez‐Davies, Erwin Strahsburger, Emily K. Silzel, Rie Nakajima, Aarti Jain, Jacob Laster, Jui-Lin Chiang, Ya-Li Tsai, Philip Louis Felgner et al. · 2025 · npj Vaccines
79. Towards mRNA therapeutics 2.0
    Kenneth R. Chien, Kylie S. Foo, Nevin Witman · 2026 · Nature Reviews Drug Discovery
80. The Promises and Pitfalls of CRISPR-Mediated Base Editing in Stem Cells
    Poh Kuan Wong, Nurul Nadia Mohamad Zamberi, Saiful Effendi Syafruddin, Fook‐Choe Cheah, Norazrina Azmi, Jia Xian Law, Eng Wee Chua · 2023 · The CRISPR Journal
81. Non-viral and viral delivery systems for hemophilia A therapy: recent development and prospects
    Ali Rajabi Zangi, Ala Amiri, Pouya Pazooki, Fatemeh Soltanmohammadi, Hamed Hamishehkar, Yousef Javadzadeh · 2023 · Annals of Hematology
82. mRNA—From COVID-19 Treatment to Cancer Immunotherapy
    W. Kŕause · 2023 · Biomedicines
83. How the initial discovery of modified RNA enabled evasion of innate immune responses and facilitated the development of RNA therapeutics
    Mouldy Sioud · 2023 · Scandinavian Journal of Immunology
84. Recent advances and applications of the CRISPR-Cas system in the gene therapy of blood disorders
    Saeed Zanganeh, Amir Mohammad Zahedi, Mahla Sattarzadeh Bardsiri, Ali Bazı, Mahdieh Bastanifard, Sanaz Shool, Seyedeh Mehrnaz Kouhbananinejad, Alireza Farsinejad, Ali Afgar, Arman Shahabi et al. · 2024 · Gene
85. Multi-objective computational optimization of human 5′ UTR sequences
    Keisuke Yamada, Kanta Suga, Naoko Abe, Koji Hashimoto, Susumu Tsutsumi, Masahito Inagaki, Fumitaka Hashiya, Hiroshi Abe, Michiaki Hamada · 2025 · Briefings in Bioinformatics
86. Chemical Modifications in Nucleic Acid Therapeutics
    Kim A. Lennox, Rebecca C. Young, Mark A. Behlke · 2025 · Methods in molecular biology
87. Innovative translational platforms for rapid developing clinical vaccines against COVID‐19 and other infectious disease
    Ning Wang, Ting Wang · 2024 · Biotechnology Journal
88. New Bicistronic TALENs Greatly Improve Genome Editing
    José María Martín‐Fernández, Aarne Fleischer, Sara Vallejo‐Díez, Esther Palomino, Almudena Sánchez‐Gilabert, Raúl Ruiz, Yazmine Bejarano, Pere Llinàs‐Arias, Antoni Gayà, Daniel Bachiller · 2020 · Current Protocols in Stem Cell Biology
89. Beyond the Sequence: Chemical and Topological Design and Innovations in mRNA Therapeutics
    Dangliang Liu, Hongyu Chen, Alisia Pan, Xiao Wang · 2026 · Chemical Reviews
90. Recent strategies for enhanced delivery of mRNA to the lungs
    Brittany J. Heiser, Arian Veyssi, Debadyuti Ghosh · 2025 · Nanomedicine
91. Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
    Gokulnath Mahalingam, Aruna Mohan, Porkizhi Arjunan, Ajay Kumar Dhyani, Kanimozhi Subramaniyam, Yogapriya Periyasami, Srujan Kumar Marepally · 2022 · Journal of Visualized Experiments
92. Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapy
    Krishnendu Adhikary, Abhik Paul, Ayush Madan, Anas Islam, Sumel Ashique, Mohhammad Ramzan · 2025 · Advances in immunology
93. High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis
    Nikoletta Y. Papaioannou, Petros Patsali, Basma Naiisseh, Panayiota L. Papasavva, Lola Koniali, Ryo Kurita, Yukio Nakamura, Soteroula Christou, Maria Sitarou, Claudio Mussolino et al. · 2023 · Frontiers in Genome Editing
94. Optimization of a lipid nanoparticle–based protocol for RNA transfection into primary mononuclear phagocytes
    Yu Zhang, Louis‐Charles Béland, Sabrina Roussel, Nicolas Bertrand, Sébastien S. Hébert, Luc Vallières · 2024 · Journal of Leukocyte Biology
95. Detection and Quantification of 5moU RNA Modification from Direct RNA Sequencing Data
    Jiayi Li, Feiyang Sun, Kunyang He, Lin Zhang, Jia Meng, Daiyun Huang, Yuxin Zhang · 2024 · Current Genomics
96. Trans-m5C: A transformer-based model for predicting 5-methylcytosine (m5C) sites
    Haitao Fu, Zewen Ding, Wen Wang · 2024 · Methods
97. Intracellular RNase activity dampens zinc finger nuclease-mediated gene editing in hematopoietic stem and progenitor cells
    Christopher W. Peterson, Rasika Venkataraman, Sowmya Somashekar Reddy, Dnyanada Pande, Mark Enstrom, Stefan Radtke, Olivier Humbert, Hans‐Peter Kiem · 2021 · Molecular Therapy — Methods & Clinical Development
98. Future prospects in mRNA vaccine development
    Londiwe Simphiwe Mbatha, Jude Akinyelu, Fiona Maiyo, Tukayi Kudanga · 2023 · Biomedical Materials
99. The Synergy between CRISPR and Chemical Engineering
    Cia‐Hin Lau, Chung Tin · 2019 · Current Gene Therapy
100. Quantitative Profiling of Human Translation Initiation Reveals Regulatory Elements that Potently Affect Endogenous and Therapeutically Modified mRNAs
     Cole J.T. Lewis, Li Xie, Shivani Bhandarkar, Danni Jin, Kyrillos Abdallah, Austin S. Draycott, Yixuan Chen, Carson C. Thoreen, Wendy V. Gilbert · 2024 · bioRxiv (Cold Spring Harbor Laboratory)